Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiac398 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Yuxin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix, Papillomavirus Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
Women with human immunodeficiency virus (WWH) have an elevated risk for human papillomavirus (HPV)-associated anal cancer. Primary anal cancer screening results from this population could inform practice guidelines.
Methods
In total, 381 WWH with anal cytology screening, high-risk HPV (hrHPV) testing and genital (cervical or vaginal) cotesting within 6 months were identified during 2012–2019. Those with anal cytology of atypical squamous cells of undetermined significance (ASCUS) or worse underwent high-resolution anoscopy and biopsy. Independent predictors of anal hrHPV, HPV16, and histological anal high-grade squamous intraepithelial lesions (aHSIL) were identified using adjusted logistic regression models.
Results
Prevalence of anal hrHPV, HPV16, and ASCUS or worse cytology was 61%, 13%, and 68%. Histological aHSIL was detected in 42% of WWH with ASCUS or worse anal cytology. Prevalence of genital hrHPV, HPV16, and ASCUS or worse cytology was 30%, 4%, and 28%. Genital hrHPV predicted anal hrHPV (odds ratio [OR], 5.05), while genital HPV16 predicted anal HPV16 (OR, 9.52). Genital hrHPV and anal HPV16 predicted histological aHSIL (ORs, 2.78 and 10.9).
Conclusions
Anal HPV disease was highly prevalent in this primary screening cohort of WWH. While genital screening results predicted anal disease, rates of isolated anal HPV disease were substantial, supporting universal anal cancer screening for this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Keith Sigel
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Liu, Y., Weiss, K., Zamudio, A. R., Hayes, M. P., Saleh, M., Gaisa, M. M., & Sigel, K. (2023). Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac398
Vancouver
Liu Y, Weiss K, Zamudio AR, Hayes MP, Saleh M, Gaisa MM, et al. Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac398
BibTeX
@article{Liu2023,
author = {Liu, Yuxin and Weiss, Kevin and Zamudio, Andrés Ramírez and Hayes, Monica Prasad and Saleh, Mona and Gaisa, Michael M and Sigel, Keith},
title = {Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiac398}
}
EUVIMED